Indian F&O data, and the evidence about what not to trade · educational
ALKEM · Healthcare
1M / 3M / 1Y
-7.5% / -2.3% / -6.5%
Traded value (60d med)
₹61 cr
Days in F&O ban since 2020
0
Futures OI / 1d change
1.5M / +0.0M
ATM implied vol
19% (vs 15% realized)
📜 Results-day history
Typical move 1.1% · up on the day 37% of 27 events · moved 4%+ in 15% · worst -7.7% / best +5.1%
| Reaction day | Move | Open gap | Next 5d | Announced |
|---|
| 2026-07-27 | -0.4% | +1.1% | +1.7% | after close |
| 2026-04-28 | +1.4% | +0.0% | -0.3% | after close |
| 2026-01-28 | -0.5% | -0.1% | -1.2% | after close |
| 2025-10-24 | +0.2% | +0.6% | -0.7% | after close |
| 2025-07-30 | +0.6% | +0.0% | -4.5% | during mkt |
| 2025-05-02 | -0.8% | +0.1% | -2.6% | after close |
| 2025-01-24 | -3.1% | +0.0% | +0.8% | during mkt |
| 2024-11-14 | -0.8% | -0.1% | +1.1% | after close |
Educational data reference: NOT investment advice. Historical statistics do not predict future results. We are not SEBI-registered advisers. All data from NSE public sources; figures may contain errors. Trading, especially leveraged F&O, can cause significant losses.